On July 24, 2023, the United States Patent and Trademark Office (USPTO) announced updated procedures for the interim Director Review (DR) of Patent Trial and Appeal Board (PTAB) decisions. The updated procedures could help patent practitioners manage costs by providing a new mechanism for recourse following PTAB decisions.
Tamaria is an associate in the Litigation Department, and a member of the Life Sciences Patent practice. Her primary area of focus is in the area of intellectual property, where she works with life sciences clients of all sizes in the preparation and prosecution of patent applications.
Prior to joining Proskauer, Tamaria was a post-doctoral fellow at the Harvard Medical School/Dana-Farber Cancer Institute, where she characterized cellular and viral determinants that dictate HIV-1 nuclear import and integration using biophysical, biochemical, virology and structural biology techniques.
While studying for her Ph.D. at Wayne State University, she defined atomic resolution structural features in clinical drug targets using X-ray crystallography and computational molecular modeling, and applied structure-activity relationships (SAR) to design protease inhibitors that restore efficacy against multi-drug resistant HIV-1 protease. As an undergraduate at Wayne State, Tamaria’s research helped to identify a link between the chaperone protein ATP12p and mitochondrial DNA stability by a detailed characterization of 24 novel yeast strains with genetic defects in ATP12 using biochemical and molecular biology methods.